BR112018014545A2 - probióticos para uso como agentes anti-inflamatórios na cavidade oral - Google Patents

probióticos para uso como agentes anti-inflamatórios na cavidade oral

Info

Publication number
BR112018014545A2
BR112018014545A2 BR112018014545-9A BR112018014545A BR112018014545A2 BR 112018014545 A2 BR112018014545 A2 BR 112018014545A2 BR 112018014545 A BR112018014545 A BR 112018014545A BR 112018014545 A2 BR112018014545 A2 BR 112018014545A2
Authority
BR
Brazil
Prior art keywords
oral cavity
microorganisms
present
probiotics
inflammatory agents
Prior art date
Application number
BR112018014545-9A
Other languages
English (en)
Inventor
Rudolf Götz Marcus
Holmgren Kerstin
Larsson Niklas
Fiebich Bernd
Wade William
Original Assignee
Symrise Ag
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise Ag, Probi Ab filed Critical Symrise Ag
Publication of BR112018014545A2 publication Critical patent/BR112018014545A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção refere-se a certos microrganismos ou misturas dos mesmos para uso no tratamento e/ou na prevenção de inflamação na cavidade oral, em particular para uso no tratamento e/ou na prevenção de cáries dentárias e/ou doenças periodontais. em particular, a presente invenção refere-se a microrganismos ou misturas dos mesmos para uso como um agente anti-inflamatório na cavidade oral para reduzir ou inibir a liberação de certos fatores inflamatórios. além disso, a presente invenção oferece composições farmacêuticas orais, produtos de higiene oral ou produtos para nutrição ou prazer compreendendo um ou mais dos microrganismos como agentes probióticos, assim como um método de produção dos mesmos.
BR112018014545-9A 2016-01-19 2017-01-18 probióticos para uso como agentes anti-inflamatórios na cavidade oral BR112018014545A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16151975.6 2016-01-19
EP16151975 2016-01-19
PCT/EP2017/051005 WO2017125447A1 (en) 2016-01-19 2017-01-18 Probiotics for use as anti-inflammatory agents in the oral cavity

Publications (1)

Publication Number Publication Date
BR112018014545A2 true BR112018014545A2 (pt) 2018-12-11

Family

ID=55237502

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018014545-9A BR112018014545A2 (pt) 2016-01-19 2017-01-18 probióticos para uso como agentes anti-inflamatórios na cavidade oral

Country Status (10)

Country Link
US (1) US11020441B2 (pt)
EP (1) EP3405205B1 (pt)
JP (2) JP7065776B2 (pt)
KR (1) KR20180102655A (pt)
CN (1) CN109069556B (pt)
AU (1) AU2017209868B2 (pt)
BR (1) BR112018014545A2 (pt)
HK (1) HK1259171A1 (pt)
NZ (1) NZ744342A (pt)
WO (1) WO2017125447A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017125447A1 (en) 2016-01-19 2017-07-27 Symrise Ag Probiotics for use as anti-inflammatory agents in the oral cavity
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
EP3351259A1 (en) 2017-01-18 2018-07-25 Symrise AG Probiotics for aggregation with disease-associated species in the oral cavity
SG11202010944RA (en) 2018-05-09 2020-12-30 Ko Biolabs Inc Lactobacillus paracasei strain and use thereof
WO2020001747A1 (en) * 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
CN111904985B (zh) * 2020-09-15 2021-10-22 广东南芯医疗科技有限公司 副干酪乳杆菌L.p R3-10在制备预防或治疗口腔炎症性疾病药物中的应用
CN113881751A (zh) * 2021-09-23 2022-01-04 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 口腔菌液载体的应用
CN113832062B (zh) * 2021-09-27 2022-10-28 微康益生菌(苏州)股份有限公司 一种副干酪乳杆菌lc86及其在预防或治疗龋齿和牙周炎上的应用
CN113712841B (zh) * 2021-11-01 2022-02-11 深圳市萱嘉生物科技有限公司 一种甘油葡萄糖苷在制备口腔护理产品中的应用
CN114606164B (zh) * 2022-04-08 2024-03-15 云南白药集团股份有限公司 一株副干酪乳杆菌Probio-01及其制备益生菌口腔制剂的用途
CN114796287A (zh) * 2022-06-09 2022-07-29 比菲德(北京)生物科技有限公司 一种可预防龋齿和清新口腔的益生菌粉及其应用
CN116694525A (zh) * 2023-06-14 2023-09-05 南昌大学 一株植物乳杆菌及其在制备抑制或缓解或治疗口腔粘膜炎菌剂的应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518615A (en) 1983-08-23 1985-05-21 Warner-Lambert Company Non-adhesive chewing gum base composition
US4721620A (en) 1986-04-01 1988-01-26 Warner-Lambert Company Polyvinylacetate bubble gum base composition
US5093136A (en) 1991-05-08 1992-03-03 Nabisco Brands, Inc. Dual gum base bubble gum
US5266336A (en) 1991-11-12 1993-11-30 Wm. Wrigley Jr. Company High flavor impact non-tack chewing gum with reduced plasticization
US5601858A (en) 1994-12-29 1997-02-11 Warner-Lambert Company Non-stick chewing gum
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US6986709B2 (en) 2001-09-21 2006-01-17 Igt Gaming device having games with variable game functions
US20040101495A1 (en) 2002-11-27 2004-05-27 Leena Nase Method for improving dental health
US20050281756A1 (en) * 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
EP1634948A1 (en) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
AU2006299243A1 (en) 2005-09-19 2007-04-12 Basf Aktiengesellschaft Microorganisms inhibiting the formation of foot malodor
HUE030542T2 (en) * 2005-10-06 2017-05-29 Probi Ab Use of Lactobacillus to treat viral infections
US20100028449A1 (en) 2006-06-06 2010-02-04 Satya Prakash Fermented milk product and use thereof
CN101190239B (zh) 2006-11-28 2010-11-03 景岳生物科技股份有限公司 含有类干酪乳杆菌的产品
WO2008074473A2 (en) 2006-12-19 2008-06-26 Basf Se Uses and methods for preventing and/or treating caries caused by mutants streptococci
AU2008230747A1 (en) 2007-03-27 2008-10-02 The Procter & Gamble Company Methods and kits for administering probiotics
AU2009271287A1 (en) 2008-06-24 2010-01-21 Wm. Wrigley Jr. Company Probiotic chewing gum method of manufacture
WO2010064373A1 (ja) 2008-12-04 2010-06-10 国立大学法人広島大学 Ｉｌ－８阻害剤およびその製造方法
EP2379091A2 (en) 2008-12-16 2011-10-26 Nestec S.A. Compositions and methods for improved oral health
AU2009341473B2 (en) * 2009-03-05 2016-04-21 Probiotical S.P.A. Bacteria strains having a high anti-inflammatory activity
EP2455095B1 (en) 2009-07-16 2017-06-07 Hiroshima University Prophylactic, ameliorating or therapeutic agent for oral diseases
DE202009011370U1 (de) 2009-08-21 2009-11-19 Dreyer Gmbh Vorrichtung zur Oberflächenbehandlung einer sich bewegenden Kunststoffschicht
DE202009011379U1 (de) 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
CN101703179A (zh) 2009-12-11 2010-05-12 江南大学 一种清除食品中微囊藻毒素的方法
CN101715908A (zh) 2009-12-11 2010-06-02 江南大学 一种提高益生菌清除微囊藻毒素效率的方法
ES2408954T3 (es) 2010-03-11 2013-06-24 Kloarys Investment Ltd Composición cosmética o farmacéutica tópica que comprende cepas probióticas de lactobacillus y uso de la misma
EP2420580A1 (en) 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
TWI572354B (zh) * 2010-09-09 2017-03-01 明治股份有限公司 抑制發炎之組成物
ES2660775T3 (es) * 2011-05-16 2018-03-26 Belano Medical Ag Nuevas bacterias del ácido láctico y composiciones que las contienen contra los resfriados bacterianos
JP5904028B2 (ja) 2012-06-19 2016-04-13 ライオン株式会社 乳酸菌及びその培養由来物、ならびにこれらを含有する組成物
CA2783414A1 (en) 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
RU2492851C1 (ru) 2012-08-02 2013-09-20 Сергей Владимирович Кузнецов Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции
WO2014140080A1 (en) 2013-03-14 2014-09-18 Nestec S.A. Lactobacillus plantarum ncc 2936 preparations and oral health
US9587284B2 (en) 2014-02-21 2017-03-07 Asian Probiotics and Prebiotics Ltd. Lactic acid bacterium having immunomodulatory and anti-allergic effects and pharmaceutical composition containing the same
TWI505832B (zh) 2014-02-21 2015-11-01 Genmont Biotech Inc 乳酸菌、其組合物與彼等於治療自體免疫疾病暨其倂發症之用途
US9399048B2 (en) 2014-03-05 2016-07-26 Asian Probiotics And Prebiotics Ltd Lactic acid bacteria and its applications in immunomodulation and anti-inflammation
CN107636145B (zh) 2014-09-30 2021-08-20 Rna公司 制备其中苷元在细胞中积累的微生物制剂的方法和通过该方法生产的微生物制剂
EP3334437A1 (en) 2015-08-25 2018-06-20 Kaleido Biosciences, Inc. Glycan compositions and uses thereof
GB201600975D0 (en) 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof
EP3196318A1 (en) * 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
WO2017125447A1 (en) 2016-01-19 2017-07-27 Symrise Ag Probiotics for use as anti-inflammatory agents in the oral cavity

Also Published As

Publication number Publication date
US20190388485A1 (en) 2019-12-26
CN109069556B (zh) 2022-11-25
KR20180102655A (ko) 2018-09-17
AU2017209868B2 (en) 2023-08-03
EP3405205B1 (en) 2020-07-15
HK1259171A1 (zh) 2019-11-29
EP3405205A1 (en) 2018-11-28
CN109069556A (zh) 2018-12-21
US11020441B2 (en) 2021-06-01
AU2017209868A1 (en) 2018-08-02
NZ744342A (en) 2022-11-25
WO2017125447A1 (en) 2017-07-27
JP7313418B2 (ja) 2023-07-24
JP2019502737A (ja) 2019-01-31
JP2022031608A (ja) 2022-02-21
JP7065776B2 (ja) 2022-05-12

Similar Documents

Publication Publication Date Title
BR112018014545A2 (pt) probióticos para uso como agentes anti-inflamatórios na cavidade oral
MX2016010213A (es) Formulaciones farmaceuticas novedosas.
PH12018502634A1 (en) Topical compositions of apremilast
BR112018014464A2 (pt) probióticos para alterar a composição de biofilmes orais
MX2023006541A (es) Formulaciones de dosis fija.
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
BR112015018827A2 (pt) composição farmacêutica oral para tratamento de mucosite oral e estomatite
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
TR201821157T4 (tr) İbandroni̇k asi̇t veya bunun farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzu ve d vi̇tami̇ni̇ i̇çeren oral uygulamaya yöneli̇k kati bi̇leşi̇m.
BR112016024621A2 (pt) composições para tratamento bucal
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
BR112018013189A2 (pt) zaragatoa para amostragem bucal e usos da mesma
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2018000262A (es) Usos terapeuticos de formulaciones de berberina.
IT201900021564A1 (it) Composizione nutraceutica o farmaceutica comprendente ferro pirofosfato per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie caratterizzate da carenza di ferro
BR112018071363A2 (pt) composições farmacêuticas orais de nicotinamida
BR112013026933A2 (pt) uso de uma combinação de pelo menos um carotenoide
PH12018500886A1 (en) Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders
MX2016005900A (es) Profarmaco mutuo que comprende acidos grasos de cadena corta y zebularina o 1'-ciano-citarabina para tratamiento del cancer.
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
UY33309A (es) Composiciones para tratamiento dental que comprenden ácidos lipoteicoicos o partes de los mismos como mono o poliglicerfosfatos
WO2017142368A3 (ko) 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물
MX2019015869A (es) Nuevas formulaciones orales de belinostat.
PH12020550104A1 (en) Salts of (r)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]